Medicines and results

Medication Safety

Interactions, dose adjustment and monitoring

Give the engine a medication list and the change being considered, and it returns what could harm this patient, why, and what to do instead. Interactions are explained by mechanism, doses are checked against kidney and liver function, age and weight, and each problem is graded by severity and urgency. The report leads with the single most important change, then gives a corrected regimen and a monitoring plan.

Who it is for

  • Hospital doctors prescribing for patients on long medication lists, on admission, at discharge or when adding a new drug
  • Clinical pharmacists and residents reviewing high-risk prescriptions such as anticoagulants, opioids and immunosuppressants
  • Specialists adding a drug from outside their field, such as an antibiotic, antifungal or antiviral, to an existing regimen

What it does

  • Explains interactions by mechanism

    Traces each interaction to its cause: a cytochrome P450 enzyme (3A4, 2D6, 2C9, 2C19 or 1A2) or P-glycoprotein inhibited or induced, an effect on absorption, or two drugs adding to the same harm, such as QT prolongation, bleeding, sedation or hyperkalaemia.

  • Adjusts doses to the patient

    Checks every dose against the patient: renal function with the estimate named (usually Cockcroft-Gault creatinine clearance unless the label uses eGFR), hepatic function by Child-Pugh class, age, body weight and frailty, and pregnancy or breastfeeding.

  • Watches the high-alert drugs

    Gives the monitoring that narrow therapeutic index and high-alert drugs need, with its timing: levels for lithium, digoxin, phenytoin, aminoglycosides, vancomycin and tacrolimus, checks for anticoagulants, insulin and opioids, and the weekly-only rule for methotrexate.

  • Grades each problem by severity

    Ranks problems as contraindicated, major, moderate or minor, with how soon each matters, and puts the interactions likely to harm this patient first instead of burying them among theoretical ones.

  • Flags pharmacogenomic and practical risks

    Notes where a genotype changes prescribing, such as CYP2C19 with clopidogrel or HLA-B*57:01 with abacavir, and practical hazards such as tablets that must not be crushed, timing with food and sick-day rules.

  • Uses the official label when it is attached

    Where US product information from DailyMed is attached to the answer, defers to it on licensed dosing, contraindications and boxed warnings, and makes clear when a recommendation goes further than the label.

How it works

  1. The clinician enters the full medication list with doses and frequencies, age, weight, kidney and liver function, pregnancy or breastfeeding status, allergies, and the change being considered.
  2. Each drug pair and the regimen as a whole are checked for mechanism-based interactions, cumulative effects, duplication and drugs without a current indication.
  3. Doses are tested against the patient's kidney and liver function, age and weight.
  4. Problems are graded by severity and timing and placed in one table, most serious first, with the action for each.
  5. The report gives a corrected regimen and a monitoring plan, then numbered references with US product labels for the named medicines.

What to include

  • The full medication list with doses and frequencies
  • Age, weight, renal and liver function
  • Pregnancy or breastfeeding status and allergies
  • The change being considered

Example cases

  • Adding clarithromycin for 7 days to simvastatin 40 mg, amlodipine 10 mg and apixaban 5 mg twice daily. What needs to change?
  • eGFR 22: metformin 1 g twice daily, gabapentin 600 mg three times daily, enoxaparin 1 mg/kg twice daily. Adjust each.
  • QTc 498 ms on citalopram 40 mg, ondansetron and methadone 60 mg. Risk and safer alternatives?

What the report contains

  1. Conclusion and Recommendation
  2. Problems Found
  3. Recommended Regimen
  4. Monitoring Plan
  5. Information Needed
  6. Key Evidence & References

Limits

  • It checks the list it is given. Over-the-counter medicines, herbal products and drugs prescribed elsewhere are missed unless they are entered.
  • Drug labels attached are US labels; licensed doses and indications differ between countries, and every dose should be confirmed against the local formulary.
  • How much an interaction matters depends on dose, duration and the individual patient. The prescriber and pharmacist remain responsible for the final regimen, and local protocols take precedence.

Frequently asked questions

Can clarithromycin be given with simvastatin?

Generally not. Clarithromycin strongly inhibits CYP3A4, which sharply increases simvastatin exposure and the risk of myopathy and rhabdomyolysis, and US product labelling contraindicates the combination. The usual options are to withhold the statin for the course of the antibiotic or to choose an antibiotic without this interaction, such as azithromycin, where that is clinically appropriate.

Which kidney function estimate should be used for drug dosing?

Most product labels base renal dose adjustment on creatinine clearance estimated by the Cockcroft-Gault equation, although some now use eGFR. Either estimate can mislead at extremes of weight or muscle mass and when kidney function is changing quickly. The engine states which estimate it used and why.

How can QT-prolonging drugs be combined safely?

Avoid combining them where possible, particularly with a QTc that is already prolonged, low potassium or magnesium, bradycardia, structural heart disease, or a drug that inhibits their metabolism. Check an ECG and electrolytes, correct deficits and choose alternatives with less effect on the QT interval. The engine adds up the QT risk across the whole regimen.

Do direct oral anticoagulants interact with other drugs?

Yes. All are substrates of P-glycoprotein, and apixaban and rivaroxaban are also metabolised by CYP3A4, so strong inhibitors can raise their levels and strong inducers such as rifampicin, carbamazepine and phenytoin can lower them. Additive bleeding risk with antiplatelet drugs and NSAIDs matters as much. The engine grades each interaction and gives the action.